NCT06789770 Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
| NCT ID | NCT06789770 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pennsylvania |
| Condition | Sleep Apnea, Obstructive |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-11-20 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2024-11-20 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will provide important new information regarding (1) the relationship between route of breathing and airway collapsibility and (2) whether route of breathing during DISE (Drug-Induced Sleep Endoscopy) is representative of natural sleep.
Eligibility Criteria
Inclusion Criteria: * • Adults (≥ 18yrs) that underwent clinical evaluation at the CPAP Alternatives Clinic at Penn Otorhinolaryngology. * Must have at least mild OSA (AHI\>5) Exclusion Criteria: * • Sleep study with an AHI\<5, \>25% of total events being central or mixed events, or inability to achieve adequate drug-induced sleep. * Upper Respiratory Illness at the time of the DISE.
Contact & Investigator
Julianna Rodin, MD
PRINCIPAL INVESTIGATOR
University of Pennsylvania
Frequently Asked Questions
Who can join the NCT06789770 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sleep Apnea, Obstructive. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06789770 currently recruiting?
Yes, NCT06789770 is actively recruiting participants. Contact the research team at seaye@pennmedicine.upenn.edu for enrollment information.
Where is the NCT06789770 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06789770 clinical trial?
NCT06789770 is sponsored by University of Pennsylvania. The principal investigator is Julianna Rodin, MD at University of Pennsylvania. The trial plans to enroll 50 participants.